Viral hepatitis B and C infections in adolescents born pre- and post-hepatitis B vaccine introduction in Calabar, Nigeria

Submitted: 20 March 2023
Accepted: 29 June 2023
Published: 13 September 2023
Abstract Views: 182
PDF: 21
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Hepatitis B and C Virus (HBV, HCV) infections are major contributors to the burden of chronic liver diseases globally. In a bid to curb the HBV infection, the Nigerian Government introduced the HBV vaccine into the National Program on Immunization (NPI) in 2004.This study aimed to determine the prevalence and associated factors of HBV and HCV infections among adolescents in secondary schools in Calabar, Cross River State, South-South Nigeria, in the pre- and post-vaccination era. This was a school-based, cross-sectional study. Six hundred and sixty secondary school adolescents, aged 10-20 years, were recruited using multi-staged sampling technique. Hepatitis B Surface Antigen (HBsAg) and HCV antibody screening were done respectively on the study participants using rapid chromatographic immunoassay method. The relationship between sociodemographic variables and Hepatitis B infection were described. A p-value of less than 0.05 was considered significant. The mean age of the participants was 14.85±2.11 years. Six participants were positive for HBsAg, giving an overall prevalence of 0.9%. The positive adolescents were from public schools, and the age group mostly positive was 16 years and above (2.1%). None of the screened adolescents was positive for HCV antibody. Though the prevalence of HBV infection was low, most of those positive were delivered before the introduction of the HBV vaccine into the NPI schedule. Modalities to vaccinate young people delivered before the introduction of Hepatitis B vaccine into the NPI schedule should be developed.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

World Health Organization. Hepatitis B Fact Sheet. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
World Health Organization. Hepatitis C Fact Sheet. 2021 Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
World Health Organization. Global Hepatitis Report. 2017. Available from: https://www.who.int/publications/i/item/9789241565455
World Health Organization. Introduction of Hepatitis B vaccine into childhood immunization services. 2001. Available from: http://www.who.int/vaccines-documents
Do Livramento A, de Cordova CMM, Spada C, Treitinger A. Seroprevalence of hepatitis B and C infection markers among children and adolescents in the southern Brazilian region. Rev Inst Med Trop Sao Paulo 2011;53:13-7. DOI: https://doi.org/10.1590/S0036-46652011000100003
Ajuwon BI, Yujuico I, Roper K, et al. Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019. BMC Infectious Diseases 2021;21:1120. DOI: https://doi.org/10.1186/s12879-021-06800-6
Population and Housing Census of the Federal Republic of Nigeria: Cross River State. 2016. Available from: https://www.citypopulation.de/php/nigeriaadmin.php?adm1id=NGA009. 7.
Araoye MO. Research Methodology with statistics for health and social sciences. In: Subject Selection, Nathadex Publishers, Ilorin, Nigeria. 2004;1:30-1.
Adoga MP, Gyar SD, Pechulano S, et al. Hepatitis B virus infection in apparently healthy urban Nigerians: data from pre-vaccination tests. J infect Dev ctries 2010;4:397-400. DOI: https://doi.org/10.3855/jidc.591
Olusanya O, Okpere E, Ezimokhai M. The importance of social class in voluntary fertility control in developing country. West Afr J Med. 1985;4:205-12.
Ikobah J, Okpara H, Elemi I, et al. The prevalence of hepatitis B virus infection in Nigerian children prior to vaccine introduction into the National Programme. Pan Afr Med J 2016;23:128. DOI: https://doi.org/10.11604/pamj.2016.23.128.8756
Uleanya ND, Obidike EO. Prevalence and risk factors of hepatitis B virus transmission among children in Enugu, Nigeria. Niger J Paed 2015;42:199-203. DOI: https://doi.org/10.4314/njp.v42i3.5
Odusanya OO, Alufohai FE, Meurice FP, et al. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria. International Journal of Infectious Diseases. 2005;9:139-43. DOI: https://doi.org/10.1016/j.ijid.2004.06.009
Ezeilo MC, Engwa GA, Iroha RI, Odimegwu DC. Seroprevalence and associated risk factors of hepatitis B virus infection among children in Enugu Metropolis. Virology: Research and treatment 2018;9:1-7. DOI: https://doi.org/10.1177/1178122X18792859
Alikor EA, Erhabor ON. Seroprevalence of hepatitis B surface antigenaemia in children in a tertiary health institution in the Niger delta of Nigeria. Niger J Med 2007;16:250-1. DOI: https://doi.org/10.4314/njm.v16i4.37331
Tswana S, Chetsanga C, Nystrom L, et al. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe. S Afr Med J 1996;86:72-5.
Aderibigbe SA, Akinola D, Ameen HA, et al. Risk Exposure to Hepatitis B infection among Senior Secondary School Student in a metropolitan City of North-Central Nigeria. Ethiopian Journal of Health Development. 2016;30.
Lohoues-Kouacou M-J, Assi C, Simen-Kepeu A, et al. Prevalence of HBV sero-markers in two Different Socioeconomic Groups of School Children from Abidjan, Cote d'lvoire J Gastroenterol Hepatol Res 2013;2.
Ndako JA, Nwankiti OO, Echeonwa GON, et al. Studies on Prevalence and Risk factors for Hepatitis B Surface Antigen among Secondary School Students in Northcentral, Nigeria. Sierra Leone J Biomed Res 2011;3:163-8.
Ugwuja E, Ugwu N. Seroprevalence of Hepatitis B Surface Antigen and Liver Function Tests among Adolescents in Abakaliki, South-eastern Nigeria. The Internet Journal of Tropical Medicine 2009;6. DOI: https://doi.org/10.5580/297
Al-Faleh FZ, Ayoola EA, Arif M, et al. Seroepidemiology of hepatitis B virus infection in Saudi Arabian Children: a baseline survey for mass vaccination against hepatitis B. J Infect 1992;24:197-206. DOI: https://doi.org/10.1016/0163-4453(92)93006-C
Chukwuka JO, Ezechukwu CC, Egbuonu I. Cultural influences on hepatitis B surface antigen seropositivity in primary school children in Nnewi. Nig J Paediatr 2003;30:140-2. DOI: https://doi.org/10.4314/njp.v30i4.12077
Eke CB, Ogbodo SO, Ukoha OM, et al. Seroprevalence and Risk Factors of Hepatitis B Virus Infection among Adolescents in Enugu, Nigeria. Journal of Tropical Pediatrics 2015;61:407-13. DOI: https://doi.org/10.1093/tropej/fmv035
Scaraveli NG, Passos AM, Voigt AR, et al. Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil. Cad Saude Publica 2011;27:753-8. DOI: https://doi.org/10.1590/S0102-311X2011000400014
Voigt R, Neto MS, Spada C, Treitinger A. Seroprevalence of hepatitis b and hepatitis C markers among children and adolescents in the south Brazilian region—metropolitan area of Florianopolis, Santa Catarina. Brazilian Journal of Infectious Diseases 2010;14:60-5. DOI: https://doi.org/10.1016/S1413-8670(10)70012-X
Ikobah JM, Okpara HC, Agbor IE, et al. Asymptomatic Hepatitis C Infection in Nigerian Adolescents. EC Gastroenterology and Digestive System 2017;4:113-8.

How to Cite

Ikobah, J. M., Ada, M., Uhegbu, K., Sunday, E., Otu, V., Okoi-Obuli, J., & Ekanem, E. (2023). Viral hepatitis B and C infections in adolescents born pre- and post-hepatitis B vaccine introduction in Calabar, Nigeria. Annals of Clinical and Biomedical Research, 4(2). https://doi.org/10.4081/acbr.2023.321